AcelRx Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Talphera

16/05/2022 14:32

* AcelRx Pharmaceuticals Inc  ACRX.OQ  reported a quarterly
adjusted loss of 6 cents​​ per share for the quarter ended in
March. The mean expectation of two analysts for the quarter was
for a loss of 6 cents per share.
    * Revenue fell 13.5% to $442.00 thousand from a year ago; 
analysts expected $550.00 thousand. 
    * AcelRx Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 6 cents​.
    * The mean earnings estimate of analysts had risen by
about 25% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * AcelRx Pharmaceuticals Inc shares had fallen by 26.5% this
quarter and lost 62.5% so far this year.
    * The company reported a quarterly loss of $8.67 million.
    * Wall Street's median 12-month price target for AcelRx
Pharmaceuticals Inc is $4.25 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 01:32 p.m.  ​All
figures in US dollars unless otherwise stated